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SUMMARY
Deletion of self antigen-specific T cells during thymic development provides protection from 
autoimmunity. However, it is unclear how efficiently this occurs for tissue-restricted self antigens, 
or how immune tolerance is maintained for self antigen-specific T cells that routinely escape 
deletion. Here we show that endogenous CD4+ T cells with specificity for a set of tissue-restricted 
self antigens were not deleted at all. For pancreatic self antigen, this resulted in an absence of 
steady-state tolerance, while for the lung and intestine, tolerance was maintained by the enhanced 
presence of thymically-derived antigen-specific Foxp3+ regulatory T (Treg) cells. Unlike 
deletional tolerance, Treg cell-mediated tolerance was broken by successive antigen challenges. 
These findings reveal that for some tissue-restricted self antigens, tolerance relies entirely on 
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nondeletional mechanisms that are less durable than T cell deletion. This may explain why 
autoimmunity is often tissue-specific, and offers a rationale for cancer vaccine strategies targeting 
tissue-restricted tumor antigens.
INTRODUCTION
To enable recognition of virtually any pathogen, the adaptive immune system harbors a vast 
diversity of T cell clones, each with a unique T cell antigen receptor (TCR) that is randomly 
generated during development in the thymus. To prevent autoimmunity, T cell clones with 
high TCR reactivity to self antigens presented in the thymus are deleted through negative 
selection, leaving behind a peripheral repertoire of mature T cells that is largely foreign 
antigen-specific (Hogquist et al., 2005). This basic model of central tolerance applies not 
only to ubiquitous self antigens, but also to "tissue-restricted" self antigens that are normally 
absent from the thymus. This is possible due to broad patterns of antigen presentation by the 
panoply of specialized antigen-presenting cell types found in the thymus (Klein et al., 2009), 
including medullary thymic epithelial cells that express tissue-restricted genes 
promiscuously through the activity of the transcriptional regulator Aire (Mathis and Benoist, 
2009).
Despite the efficiency of thymic selection and the fact that some self antigen-specific T cells 
are also deleted in the periphery (Metzger and Anderson, 2011; Redmond and Sherman, 
2005), the mature peripheral T cell repertoire is known to harbor significant self antigen 
specificity (Hogquist and Jameson, 2014), a point made clear by numerous experimental 
models of autoimmunity that are induced by immunization with self antigens. However, the 
extent to which central tolerance fails and self antigen-specific T cells escape deletion is 
unclear, particularly in the case of tissue-restricted self antigens.
The identity of self antigen-specific T cells in the peripheral repertoire is of paramount 
importance, as these cells are likely involved in autoimmunity as well as anti-tumor 
immunity. Some of these cells may simply be ignorant of self antigens that are rare or poorly 
sampled by dendritic cells. Alternatively, these cells may exist in a hyporesponsive state of 
anergy, the induction of which can constitute a nondeletional mechanism of tolerance (Choi 
and Schwartz, 2007). In the case of CD4+ T cells, many self antigen-specific T cells are 
thought to be regulatory T (Treg) cells that suppress rather than promote immunity 
(Sakaguchi et al., 2008). While some Treg cells differentiate from conventional CD4+ T 
cells (Tconv) in the periphery, most are generated in the thymus through TCR recognition of 
self antigens in a process that diverges from negative selection (Josefowicz et al., 2012). 
Comprehensive analyses of TCR repertoires have shown that the specificities of CD4+ Treg 
and Tconv cell subsets exhibit limited overlap, suggesting that Treg cell specificity is biased 
towards self antigens (Hsieh et al., 2012).
Our understanding of self antigen specificity within the T cell repertoire has been hampered 
by the technical challenges of studying self antigen-specific T cells. The frequency of T cells 
with specificity to any single foreign peptide:MHC epitope is extremely small, estimated in 
the range of 1 to 100 per million CD8+ T cells, or 0.1 to 10 per million CD4+ T cells 
(Jenkins and Moon, 2012). In the case of self antigen-specific T cells, which are presumably 
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impacted by deletional tolerance, these frequencies may be even lower. Hence, most studies 
of self antigen-specific T cells have involved the use of TCR transgenic mice crossed with 
mice expressing the cognate antigen (Hogquist et al., 2005; Wirnsberger et al., 2011). While 
such studies have provided important insights into various mechanisms of T cell tolerance to 
self antigens, it is now clear that in vivo systems involving abnormally high frequencies of 
monoclonal T cells often fail to accurately model the development of self antigen-specific T 
cells (Bautista et al., 2009; Leung et al., 2009). To overcome these limitations, we have 
developed peptide:MHCII tetramer-based cell enrichment techniques to enable direct 
characterization of self antigen-specific CD4+ T cells within completely unmanipulated 
endogenous T cell repertoires (Moon et al., 2007; 2011). Using this approach, we previously 
revealed that a significant proportion of a CD4+ T cell population specific for a ubiquitous 
self antigen survives deletion, which raised the question of how efficiently T cell tolerance is 
established to self antigens with more limited patterns of expression.
In this study, we created an experimental system in which a model self antigen was 
expressed in mice through different tissue-specific promoters, and the development of the 
same endogenous antigen-specific CD4+ T cell population was compared across each of 
these strains. This enabled us to isolate the effects of self antigen tissue localization on 
CD4+ T cell deletion and Treg cell development in a highly controlled, extremely 
physiological in vivo context. We found that tissue-restricted expression of this self antigen 
was met with a profound lack of antigen-specific T cell deletion, which depending on the 
tissue site of expression, resulted in either an absence of steady-state tolerance, or tolerance 
maintained by antigen-specific Treg cells.
RESULTS
Absence of deletional T cell tolerance to tissue-restricted self antigens
To investigate how T cell tolerance to a self antigen is affected by the tissue environment in 
which it is expressed, we modeled Cre recombinase as a neo self antigen. Cre is a 
Bacteriophage P1 protein that is normally absent in laboratory mice (Kasman, 2005), and 
can thus serve as a tissue-restricted self antigen in various Cre transgenic mouse strains. 
RIP-Cre (rat insulin promoter), CC10-Cre (Clara cell specific promoter), and Vil-Cre (villin 
promoter) transgenic mice were used to model self antigen expression in pancreatic β islets, 
lung epithelium, and intestinal epithelium, respectively, while UbC-CreER transgenic mice 
served as controls for ubiquitous self antigen expression. Quantitative RT-PCR analysis 
confirmed tissue-restricted expression patterns of Cre mRNA in these mice (Figure 1A).
We mapped an immunogenic I-Ab-restricted epitope corresponding to residues 61–71 of Cre 
which is recognized by a relatively large frequency of naive CD4+ T cells in C57BL/6 mice 
(Figures S1A–S1D), and used this for our analysis of Cre:I-Ab-specific T cells throughout 
our study. Background levels of Cre:I-Ab tetramer staining were assessed by internal CD8+ 
T cell staining controls as well as two-color double tetramer staining experiments (Figures 
S1E and S1F).
Cre:I-Ab tetramer-based magnetic cell enrichment was used to directly measure total 
numbers of rare endogenous Cre:I-Ab-specific CD4+ T cells in wild type (WT) and Cre 
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transgenic mice. Naive WT mice, in which Cre is a foreign antigen, contained endogenous 
populations of ~165 Cre:I-Ab-specific CD4+ single positive thymocytes in the thymus 
(Figures 1B and 1D), and ~185 Cre:I-Ab-specific mature CD4+ T cells in the peripheral 
lymphoid organs (Figures 1C and 1E). UbC-CreER mice contained ~60% fewer Cre:I-Ab-
specific cells in both the thymus and periphery, indicating efficient thymic negative 
selection of T cells specific for ubiquitously expressed Cre self antigen. However, Cre:I-Ab-
specific T cell numbers were not lower in the thymus or periphery of any other Cre 
transgenic mouse, indicating a marked absence of deletional T cell tolerance against Cre self 
antigen when expression was restricted to the pancreas, lung, or intestine.
To determine whether Cre:I-Ab self antigen presentation from these tissues was sufficient 
for T cell recognition, CFSE dye labeled Cre:I-Ab-specific T cells from Cre immunized WT 
mice were adoptively transferred into WT or Cre mice and monitored for cell division as an 
indication of antigen-induced activation (Figure S1G). Transferred cells divided in CC10-
Cre, Vil-Cre, and UbC-CreER mice, but only showed minimal signs of division in RIP-Cre 
mice, indicating efficient presentation of Cre:I-Ab complexes from Cre-expressing lung and 
intestinal tissues, but only poor presentation from pancreatic tissues.
Nondeletional T cell tolerance to lung and intestinal tissue-restricted self antigens
Cre:I-Ab-specific T cells in Cre transgenic mice generally expressed low levels of CD44 that 
was consistent with a naive phenotype (Figures 1B and 1C), and we did not observe obvious 
phenotypic markers that distinguished them from their counterparts in WT mice (data not 
shown). To test the function of these T cells, we subcutaneously immunized each of the Cre 
transgenic strains with Cre peptide emulsified in complete Freund's adjuvant (CFA) and 
measured their proliferative response 7 days later. As expected, Cre:I-Ab-specific T cells 
expanded robustly in WT mice and poorly in UbC-CreER mice (Figures 2A and 2B). T cell 
expansion in RIP-Cre mice was equivalent to that in WT mice, revealing a lack of pre-
established Cre-specific tolerance when Cre expression was restricted to the pancreas. In 
contrast, T cell expansion in CC10-Cre and Vil-Cre mice was markedly lower than that in 
WT mice despite the similar frequencies of precursor cells in all these mice. Overall, there 
was no correlation between Cre:I-Ab-specific precursor and expanded T cell numbers among 
our panel of mice (Figure 2C), indicating that Cre:I-Ab-specific T cell tolerance was not a 
result of T cell deletion.
Previous studies have shown that thymic negative selection of T cells preferentially affects 
clones with the highest avidity TCRs (Moon et al., 2011; Zehn and Bevan, 2006). Analysis 
of Cre:I-Ab tetramer staining intensity, which provided a rough measure of Cre:I-Ab-specific 
TCR avidity, did not reveal differences in TCR avidity for any of the Cre transgenic mice 
except UbC-CreER (Figures 2D and 2E), nor were there any differences in overall TCR 
expression levels as evidenced by CD3 staining (Figure S2). Overall, there was no 
correlation between tetramer staining intensity and the extent of T cell expansion among the 
mice (Figure 2F), indicating that the impaired responsiveness of Cre self antigen-specific T 
cells in CC10-Cre and Vil-Cre mice was not the result of developmental selection against 
high avidity T cell clones.
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The tolerance of Cre:I-Ab-specific T cells was further evidenced by our analysis of CD4+ T 
cell effector functions. While 30–35% of the Cre:I-Ab-specific T cells in WT or RIP-Cre 
mice expressed IL-17 upon in vitro restimulation with PMA plus ionomycin, only 5–15% of 
these cells did so in CC10-Cre, Vil-Cre, and UbC-CreER mice (Figures 3A and 3B). 
Analysis of other cytokines did not reveal a diversion into alternative Th subsets (Figure 
S3). Expression of the chemokine receptor CXCR5, which enables T cells to migrate to 
lymph node B cell zones (Crotty, 2011), occurred in a subset of Cre:I-Ab-specific T cells 
distinct from those producing IL-17 (Figure 3C). While the proportion of cells expressing 
CXCR5 was similar in all of the mice in our panel (Figures 3D and 3E), the development of 
Cre:I-Ab-specific germinal center follicular helper T cells (GC-Tfh), as defined by the subset 
of PD-1+CXCR5+ T cells expressing the highest levels of these markers (Crotty, 2011), was 
strikingly impaired in CC10-Cre, Vil-Cre, and UbC-CreER mice, but not RIP-Cre mice 
(Figures 3D and 3F). Thus, the reduced proliferative potential of tolerant Cre self antigen-
specific T cells was paralleled by functional defects in cytokine production and GC-Tfh 
development.
Treg cell-mediated tolerance to lung and intestinal self antigens
It was possible that steady-state presentation of Cre self antigen resulted in the development 
of Cre:I-Ab-specific T cell populations that are intrinsically hyporesponsive to Cre 
stimulation, perhaps through the induction of anergy or development into Tregs. 
Alternatively, the nonresponsiveness of these cells may have been maintained by steady-
state interactions with tolerogenic dendritic cells presenting Cre antigen. To determine the 
role that the Cre antigen expressing environment plays in the tolerance of Cre:I-Ab-specific 
T cells, whole repertoires of purified CD4+ T cells from WT or Cre-expressing mice were 
transferred into congenic host mice lacking Cre expression. Smarta TCR transgenic mice 
were chosen as hosts because they lack endogenous T cell specificity to Cre, yet provide a 
lymphoreplete environment that limits donor T cell activation from homeostatic 
proliferation (Sprent and Surh, 2011). As shown in Figure S4A, Cre:I-Ab-specific T cells 
transferred from CC10-Cre or Vil-Cre mice into Cre antigen-free Smarta mice were still 
impaired in their ability to expand following immunization, demonstrating that tolerance 
was intrinsic to them at either the cell or population level.
In light of these results, an attractive hypothesis was that many of the Cre:I-Ab-specific T 
cells in our Cre transgenic mice were Tregs. We have previously shown that Foxp3+ Treg 
subsets are a general feature of all antigen-specific CD4+ T cell populations, and the 
frequency of these cells was elevated in a population specific for a ubiquitously expressed 
self antigen (Moon et al., 2011). Using a Foxp3EGFP reporter gene that was bred into all of 
our mouse strains (Haribhai et al., 2007), we found that ~15% of the Cre:I-Ab-specific CD4+ 
T cells in the peripheral lymphoid organs of WT mice expressed Foxp3 (Figures 4A and 
4B). This proportion was similar in RIP-Cre mice, but elevated to ~27% and ~22% in 
CC10-Cre and Vil-Cre mice, respectively, which correlated with their immune tolerance to 
Cre. Examination of total Foxp3+ and Foxp3− Cre:I-Ab-specific T cell numbers in each 
mouse revealed that the greater representation of Tregs did not come at the expense of 
Tconv cells (Figure 4C), albeit the elevated numbers of Tregs was too small to significantly 
alter the size of the total Cre:I-Ab-specific T cell population (Figure 1E). During 
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immunization, Cre-specific Tregs proliferated along with their conventional counterparts in 
all mice, but their representation was still only elevated in CC10-Cre and Vil-Cre mice 
(Figure S4B–S4E).
To test the role of Tregs in Cre-specific tolerance, Cre transgenic mice were crossed to 
Foxp3-DEREG mice, which enabled systemic ablation of Foxp3+ Tregs upon administration 
of diphtheria toxin (DT) (Lahl et al., 2007). Treg ablation during Cre immunization of 
CC10-Cre and Vil-Cre mice resulted in partial restoration of Cre:I-Ab-specific T cell 
expansion and complete restoration of IL-17 production (Figures 4D and 4E). In contrast, 
Treg ablation did not restore these functions in UbC-CreER mice, where tolerance was 
mediated by deletion. To test whether Tregs were sufficient in mediating Cre-specific 
tolerance, we transferred purified populations of total CD4+CD25+ Tregs from WT or Cre 
transgenic mice into congenically marked WT mice before immunizing them with Cre 
(Figure 4F). Transferred Tregs from CC10-Cre and Vil-Cre mice, but not WT, RIP-Cre, or 
UbC-CreER mice, potently suppressed proliferation of host Cre:I-Ab-specific T cells. 
Therefore, Cre self antigen-specific Tregs from these mice were necessary and sufficient to 
mediate Cre-specific tolerance.
Peripheral expansion of thymically derived Treg cells
The majority of Foxp3+ Tregs are either derived directly from thymic development (tTreg) 
or are induced from CD4+ Tconv cells in the periphery (pTreg) (Abbas et al., 2013; 
Josefowicz et al., 2012). Cre:I-Ab-specific Foxp3+ Tregs in our mice uniformly expressed 
both Helios and Neuropilin-1, which was consistent with a tTreg phenotype (Figure S5A) 
(Thornton et al., 2010; Yadav et al., 2012). However, CC10-Cre and Vil-Cre mice did not 
contain higher frequencies of Foxp3+ Cre:I-Ab-specific thymocytes, suggesting that thymic 
Treg development was not enhanced in these mice (Figure 5A). To better investigate their 
origin, we utilized the Foxp3ΔCNS1 mouse model in which peripheral induction of pTregs is 
impaired due to the deletion of CNS1, a critical TGFβ-responsive regulatory region in the 
Foxp3 locus (Zheng et al., 2010). Irradiated WT or Vil-Cre mice were reconstituted with 
congenic WT or Foxp3ΔCNS1 bone marrow, and the extent of Cre:I-Ab-specific Foxp3+ Treg 
development in the resulting chimeric animals was assessed. As shown in Figure 5B, the 
proportion of Cre:I-Ab-specific T cells expressing Foxp3 in Vil-Cre host mice was not 
affected by the absence of Foxp3-CNS1, indicating that these cells were not pTregs, but 
rather tTregs. Moreover, Vil-Cre mice reconstituted with Foxp3ΔCNS1 bone marrow still 
exhibited impaired Cre:I-Ab-specific T cell expansion upon immunization, indicating that 
pTregs in general were dispensable for Cre-specific tolerance (Figure S5B).
The tTreg phenotype of Cre:I-Ab-specific Tregs in our mice suggested that their 
development might be driven by ectopic Cre antigen expression in the thymus, possibly via 
the transcriptional regulator Aire, which has been shown to be required for Treg 
development to some, but not all, self antigens (Aschenbrenner et al., 2007; Malchow et al., 
2013; Perry et al., 2014). However, crossing Vil-Cre mice onto an Aire-deficient background 
did not alter the development of Cre:I-Ab-specific Tregs (Figure 5C) or their ability to 
induce tolerance (Figure S5C), arguing against a role for Aire in our experimental system. In 
addition, Batf3-dependent CD8α+ dendritic cells, which have been shown to help mediate 
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presentation of Aire-regulated genes to developing thymocytes (Perry et al., 2014), were 
also dispensable for Cre:I-Ab-specific Treg development and tolerance, as shown by our use 
of Batf3-deficient mice (Figures 5D and S5D). Although we did not detect Cre mRNA in 
whole thymus preps (Figure 1A), we performed RT-PCR analysis on flow-sorted thymic 
epithelial cells (TECs) to improve sensitivity to the point where we could reliably detect 
expression of Ins2, a known Aire-regulated gene (Anderson et al., 2002) (Figure 5E). While 
Cre mRNA expression was readily detected in TECs from UbC-CreER mice, it was 
undetectable in WT or any of the other Cre transgenic mice. Therefore, the elevated levels 
of Cre:I-Ab-specific tTregs in CC10-Cre and Vil-Cre mice were unlikely to be the result of 
thymic Cre antigen presentation.
Tonic TCR signaling has been implicated in the maintenance and function of mature Tregs 
(Levine et al., 2014; Moran et al., 2011; Vahl et al., 2014), so an alternative possibility was 
that Cre:I-Ab-specific Tregs underwent some level of clonal expansion upon antigen 
encounter in the periphery. In support of this hypothesis, expression analysis of the cellular 
proliferation marker Ki-67 revealed more steady-state cell cycle activity within the Cre:I-
Ab-specific Foxp3+ Tregs of CC10-Cre, Vil-Cre, and UbC-CreER mice than WT or RIP-Cre 
mice (Figures 5F and S5E). Notably, the Cre:I-Ab-specific Foxp3− T cells of these mice did 
not express higher levels of Ki-67, suggesting that only Cre:I-Ab-specific Tregs and not 
Tconv cells were proliferating in response to Cre self antigen.
Limited durability of steady-state Treg cell-mediated tolerance
Tregs have been shown to establish immune memory (Rosenblum et al., 2011), so we asked 
whether Cre-specific tolerance in CC10-Cre and Vil-Cre mice would be enhanced or 
diminished upon successive immune challenges. Cre peptide emulsified in CFA is not 
efficiently cleared after injection, thereby complicating interpretations of immune memory. 
Therefore, we utilized the bacterium Listeria monocytogenes, which is quickly cleared after 
infection, as an alternative antigen delivery system to induce acute primary Cre-specific T 
cell responses (Pamer, 2004). We infected mice systemically with a recombinant strain of 
Listeria (Lm-Cre) expressing Cre 61–71 peptide embedded in chicken ovalbumin (OVA). 
This resulted in Cre:I-Ab-specific T cell expansion and GC-Tfh cell development that 
mirrored the patterns of tolerance seen with peptide immunization (Figures S6A, S6C, and 
S6E). Notably, T cell responses to the endogenous Listeria Listeriolysin O (LLO) antigen 
were equivalent in all mice (Figures S6B, S6D, and S6F), indicating that a single Cre:I-Ab 
epitope-specific population of Tregs was insufficient to mediate bystander suppression of 
other Listeria antigen-specific T cell responses.
Lm-Cre infected mice were given 4 weeks to recover and were then rechallenged with Cre 
peptide + CFA (Figure 6A). In contrast to the primary immune response, Cre:I-Ab-specific 
T cells in rechallenged CC10-Cre and Vil-Cre mice now exhibited robust expansion, 
cytokine production (IL-17 and IFNγ), and GC-Tfh development that was equivalent to WT 
controls (Figures 6A, 6B, 6D, 6E, S6G, and S6H). Moreover, the expansion of Cre:I-Ab-
specific T cells now correlated directly with the number of Cre:I-Ab-specific precursors 
before secondary challenge (Figure 6C), indicating a loss of nondeletional tolerance. In 
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contrast, Cre:I-Ab-specific T cells in UbC-CreER mice remained unresponsive as before, 
demonstrating the greater durability of deletional tolerance.
The loss of tolerance and expansion of Cre:I-Ab-specific T cells also resulted in their influx 
into the pancreas, lungs, and intestines (Figure 6F and S6I). Notably, the extent of Cre:I-Ab-
specific T cell accumulation was greater in tissues expressing Cre, concordant with a role for 
antigen recognition in T cell migration or retention in nonlymphoid tissues (Figure 6G). 
Although Cre:I-Ab-specific Foxp3+ Tregs were not observed in any of these tissues (data not 
shown), none of these mice exhibited obvious signs of autoimmunity with the exception of 
RIP-Cre mice, which experienced a slight and transient increase in blood glucose levels 
(Figure 6H and data not shown). Therefore, breaking tolerance to a single self antigen 
epitope resulted in strong epitope-specific effector T cell functions, but this was not enough 
to initiate sustained autoimmunity.
To investigate the mechanism by which Cre:I-Ab-specific tolerance was lost in CC10-Cre 
and Vil-Cre mice, we compared Cre:I-Ab-specific Treg populations present in these mice 
just before primary and secondary immunizations. Both the proportions and numbers of 
Tregs within the Cre:I-Ab-specific T cell population analyzed just before secondary 
challenge (Figure 7A and 7B) were substantially reduced from that prior to primary 
immunization (Figure 4B). Furthermore, when purified populations of total CD4+CD25+ 
Tregs were transferred from these mice into WT recipients, host T cell responses to peptide 
+ CFA immunization were no longer suppressed as before (Figures 7C and 4F). 
Collectively, these results indicate that the loss of tolerance after immunization was the 
result of a new equilibrium established between Cre:I-Ab-specific Treg and Tconv subsets.
DISCUSSION
By studying an endogenous CD4+ T cell population with specificity for a single epitope of a 
self antigen expressed under different tissue-restricted patterns, we have provided direct 
evidence that deletional T cell tolerance is minimal to nonexistent for some tissue-restricted 
self antigens. Rather, mature T cell populations with specificity to such self antigens may be 
largely ignorant, as we observed in the case of pancreatic expression, or may develop 
steady-state tolerance through enhanced antigen-specific Treg activity, as observed in the 
case of lung and intestinal expression. These findings support the concept that T cell 
tolerance to some tissue-restricted self antigens are shaped entirely by nondeletional 
processes outside the thymus.
Our conclusion that Cre-specific T cells do not undergo deletion in tissue-restricted Cre-
expressing mice is based on our direct measurements of endogenous antigen-specific T cell 
frequencies in both the thymic and peripheral T cell compartments of WT and Cre-
expressing mice. Our findings are congruous with recent tetramer-based studies by Davis 
and colleagues showing that the frequencies of several self antigen-specific T cell 
populations in humans are in the same range as frequencies for foreign antigen-specific 
populations (Su et al., 2013; Yu et al., 2015). While it is formally possible that the presence 
of Cre antigen caused the deletion of some Cre-specific T cell clones while promoting the 
development of others, resulting in no net change in frequency, our data shows that any such 
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changes in the Cre-specific T cell repertoire did not result in notable differences in the TCR 
avidities of these T cells. Moreover, the elevated numbers of Foxp3+ Cre-specific T cells in 
CC10-Cre and Vil-Cre mice were not offset by lower numbers of Foxp3− cells, suggesting 
that Tconv cells were not being diverted into a Treg fate in the thymi of these mice.
Our results contrast with our previous findings of robust negative selection against T cells 
specific for ubiquitously expressed self antigens (Moon et al., 2011), upholding the general 
assumption that tissue-restricted self antigens elicit less efficient deletional tolerance. The 
complete absence of T cell deletion in our current study also contrasts with a previous report 
demonstrating that about 25% of a single chain TCR transgenic CD8+ T cell population with 
specificity to a pancreas-restricted OVA model self antigen are deleted (Zehn and Bevan, 
2006). However, OVA is expressed in the thymi of the RIP-mOVA mice used in this study 
(Gallegos and Bevan, 2004), while we could not detect any thymic expression of Cre in RIP-
Cre mice. It is possible that the discrepancy in thymic expression is due to the small size of 
the RIP2 promoter used in these mice, which may be influenced by local chromatin effects 
unique to each transgene insertion site.
Interestingly, the CC10 and villin genes are both Aire-regulated (M. Anderson, personal 
communication) and expressed in medullary thymic epithelial cells (Derbinski et al., 2005). 
However, we did not detect thymic expression of Cre in CC10-Cre and Vil-Cre mice either, 
suggesting that Aire-mediated regulation of transgenic promoters may not accurately reflect 
that of their corresponding endogenous promoters. Our findings therefore may not be 
directly applicable to these endogenous self antigens or others that are regulated by Aire. 
However, it is unclear whether all tissue-restricted genes are ectopically expressed in the 
thymus through the function of Aire or other mechanisms, and whether such expression 
always results in physiological antigen presentation to thymocytes. Our colleagues 
previously showed that in the case of the eye-restricted protein IRBP, thymic expression 
through Aire results in the tolerance of T cells specific for only some of the epitopes within 
this protein, and this is due to differences in the efficiency by which these epitopes are 
presented (Taniguchi et al., 2012). Thus, it is likely that a large number of epitopes in tissue-
restricted self antigens are not routinely detected by developing thymocytes. Moreover, neo-
epitopes created by genetic mutations in tumor cells would represent another class of self 
epitopes unrepresented during thymic selection. Our findings reveal the relevant potential 
outcomes of T cell development and tolerance to those self antigens that are not thymically 
expressed or presented.
The lack of deletion in RIP-Cre mice resulted in an apparent complete lack of tolerance to 
the Cre epitope, as Cre-specific T cells in these mice responded to antigen stimulation just as 
well as those in WT mice. Our data suggest that RIP2-driven Cre expression in the pancreas 
normally results in a level of Cre:I-Ab presentation that is insufficient to activate Cre-
specific T cells under steady-state non-inflammatory conditions. However, after two rounds 
of immunization, Cre-specific T cells accumulated in the pancreas of RIP-Cre mice and 
these mice experienced elevated blood glucose levels, suggesting that inflammatory 
conditions can enhance presentation of this self antigen to a level where it is readily 
detectable by antigen-specific T cells.
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Cre-specific T cells were also spared from deletion in CC10-Cre and Vil-Cre mice, but 
tolerance to Cre was established by Cre-specific Foxp3+ Tregs that were present at elevated 
frequencies. Our data indicates that these Tregs were most likely derived from the thymus 
rather than induced from Cre-specific Tconv cells, which is consistent with the general 
belief that tTregs are predominantly specific for self antigens (Hsieh et al., 2012; Josefowicz 
et al., 2012). However, since we did not detect any thymic Cre expression or elevated 
frequencies of Cre-specific Foxp3+ thymocytes in these mice, we believe that the elevated 
frequency of Cre-specific Tregs was not the result of increased tTreg output from the 
thymus, but rather the expansion of these cells in the periphery after antigen encounter. This 
model is supported by the elevated level of cell cycle activity we found in these cells, and is 
consistent with studies indicating that Tregs experience more steady-state TCR signaling 
than Tconv cells (Fisson et al., 2003; Moran et al., 2011), which supports their persistence in 
the periphery (Levine et al., 2014; Vahl et al., 2014). In our study, only Cre-specific Treg 
and not Tconv cells exhibited increased cell cycle activity, suggesting that they are more 
responsive to self antigens. It is also possible that Tconv cells are also sensing self antigen, 
but are continuously suppressed by their Treg counterparts, as suggested by recent studies of 
human self antigen-specific CD8+ T cells (Maeda et al., 2014).
Treg-mediated tolerance to Cre in CC10-Cre and Vil-Cre mice was functionally equivalent 
to deletional tolerance in UbC-CreER mice during primary immune responses, but during a 
secondary immune challenge, this tolerance was lost while deletional tolerance in UbC-
CreER mice remained intact. Our data indicated that the balance of Cre-specific Treg and 
Tconv cells was altered such that tolerance was no longer a favorable outcome upon 
secondary challenge. However, it is also possible that the memory Tconv cells stimulated 
during the secondary antigen challenge were less susceptible to Treg-mediated suppression 
than their naive precursors. These results contrast with the suppressive Treg memory 
established in another self antigen-specific T cell study (Rosenblum et al., 2011). However, 
this earlier study involved sterile expression of self antigen through a drug-inducible 
promoter, while our study involved antigen challenges in the presence of strong microbial 
adjuvants. Thus, self antigen-specific T cell memory may be influenced by qualitative 
features of the priming autoimmune response.
Despite the loss of Treg tolerance, Cre-specific T cell numbers contracted over time and 
with the exception of some mild hyperglycemia in RIP-Cre mice, there were no signs of 
autoimmunity in our mice. While strong T cell responses against this single epitope may 
have initiated damage to Cre-expressing tissue, it is likely that Tregs specific for other 
epitopes within Cre, as well as the many other self antigens within the tissue environment, 
would have provided ample bystander suppression to eventually subdue the response. 
Conversely, during infection of Cre-expressing mice with Cre peptide-expressing Listeria, 
the single Cre epitope-specific Treg population was unable to suppress T cell responses to 
immunodominant epitopes from the bacteria. Thus, the breadth of steady-state Treg 
tolerance to several self antigens in a tissue likely supports a level of robustness that resists 
the development of autoimmunity from isolated immune responses to one or a few self 
antigen epitopes.
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Our results indicate that self antigen-specific Tregs constitute a less durable, yet more 
flexible, form of tolerance than T cell deletion. A consequence of this flexibility would be 
the immune system's ability to recruit these self antigen-specific T cells against crossreactive 
antigens expressed by pathogens or tumors. The establishment of Treg-mediated tolerance to 
the large numbers of tissue-restricted self antigens in the body would allow the immune 
system to retain a more diverse repertoire of TCR specificities than would be possible 
through deletional tolerance alone. While this could be beneficial for antimicrobial and 
antitumor immunity, it may come at a cost of higher risks for autoimmunity.
The different levels of T cell tolerance established to different tissue-restricted self antigens 
are likely attributable to the quantity and quality of self antigen presentation in the 
respective tissue environments. The lung and intestines are much larger than the pancreas, 
and moreover, they contain mucosal surfaces from which foreign antigens are continually 
sampled. As we observed in our panel of Cre mice, presentation of self antigens to 
circulating T cells may be more efficient in these types of tissues, enabling the antigen 
recognition that sustains self antigen-specific Tregs. It is also possible that the dendritic cell 
subsets draining these tissues may be more supportive for the development and maintenance 
of Tregs. The paucity of steady-state Treg tolerance to self antigens in organs like the 
pancreas may result in a greater vulnerability to the aberrant initiation of autoimmune 
responses, which we speculate could be an underlying factor for the high prevalence of 
autoimmune diseases in these organs.
The enhancement of autoantigen-specific Treg activity is a popular focus for autoimmune 
disease therapies. The feasibility of this strategy is supported by our discovery that antigen-
specific Treg activity constitutes a normal steady-state mechanism of tolerance for some 
tissue-restricted self antigens. From another standpoint, the lack of deletional tolerance and 
limited durability of Treg-mediated tolerance to tissue-restricted self antigens offers a strong 
rationale for the development of cancer vaccines targeting tissue-restricted tumor antigens.
EXPERIMENTAL PROCEDURES
Immunizations and Infections
All peptides were custom ordered from Genscript. For peptide immunizations, mice were 
injected subcutaneously at the base of the tail with 100 µg peptide in 50 µl of a 1:1 emulsion 
of PBS and complete Freund’s adjuvant (Sigma). ΔactA Listeria monocytogenes expressing 
the Cre epitope (Lm-Cre) was generated as previously described (Orr et al., 2007). Mice 
were infected intravenously at a dose of 108 cfu. For Treg ablation experiments, Foxp3-
DEREG mice were injected intraperitoneally with 75 µg/kg diphtheria toxin (List 
Biologicals) at days 1 and 2 post antigen immunization.
Tetramer-Based Cell Enrichment and Flow Cytometry
Single cell suspensions were stained with tetramer at a final concentration of 10 nM for 1 h 
at room temperature, and then magnetically enriched as described in detail (Legoux and 
Moon, 2012; Moon et al., 2007). For intracellular cytokine staining, tetramer-based cell 
enrichment was not used. Instead, total CD4+ T cells were isolated (Miltenyi) from draining 
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lymph nodes of day 7 immunized mice and restimulated in vitro for 2h at 37°C with 50 
ng/mL PMA (Sigma), 500 ng/mL ionomycin (Sigma), and 10 µg/mL brefeldin A (Sigma). 
The cells were then surface stained with tetramer and antibodies, washed, and then fixed, 
permeabilized, and stained for intracellular cytokines using the Cytofix/Cytoperm kit (BD 
Biosciences). For Ki67 expression analysis, pooled spleen and lymph node cells from 1 
immunized or 2–3 naive mice were fixed and permeabilized using the Foxp3 Fixation/
Permeabilization kit (eBioscience) prior to Ki67 antibody staining. Helios staining was 
performed with the same kit. 7–9 color flow cytometry was performed on an LSRII or 
Fortessa (BD Immunocytometry Systems). Data was analyzed with FlowJo software 
(Treestar). All antibodies were purchased from BioLegend, eBioscience, BD Pharmingen, or 
Life Technologies.
T cell Transfers
Total CD4+ T cells from the pooled spleen and lymph nodes of WT or Cre mice were 
magnetically purified (Miltenyi) and ~2 × 107 were transferred intravenously into CD45.1 or 
CD45.2 congenic Smarta mice, where ~3 × 106 cells stably engrafted. For Treg transfer 
experiments, total CD4+ CD25+ T cells from the pooled spleen and lymph nodes of WT or 
Cre mice were magnetically purified (Miltenyi) and ~4 × 106 were transferred intravenously 
into CD45.1 or CD45.2 congenic WT mice, where ~106 stably engrafted. Recipient mice 
were then immunized the next day, and host Cre:I-Ab-specific CD4+ T cells were isolated 
and analyzed 7 days later.
Irradiation Bone Marrow Chimeras
Lethally irradiated (950 rads) WT or Vil-Cre mice were reconstituted intravenously with 107 
bone marrow cells from CD45.1 or CD45.2 congenic WT or Foxp3ΔCNS1 mice. Lymphoid 
tissues from the resulting chimeric mice were harvested 7–8 weeks later for analysis of 
Cre:I-Ab-specific T cells.
Tissue T cell Isolation
Spleen and lymph nodes were mashed over 100 µm nylon mesh to create single cell 
suspensions. To prepare single cell suspensions from nonlymphoid tissues, euthanized mice 
were first perfused with 25 ml PBS. Pancreata were injected with 800 µg/ml collagenase P 
(Roche) and 40 µg/ml DNase I (Roche), incubated 15 min at 37°C, and mashed over 100 µm 
nylon mesh. Cells were then centrifuged over a 44/67% Percoll gradient (GE Healthcare) to 
isolate the lymphocyte-containing fraction. Lungs were incubated with 70 µg/ml Liberase 
TM (Roche) and 10 mM aminoguanidine (Sigma) in HEPES buffer, digested at 37°C for 30 
min, and dissociated with a gentleMACS Dissociator (Miltenyi). Pooled Peyer's patches, 
small intestine and colon lamina proprias were isolated using a Lamina Propria Dissociation 
Kit (Miltenyi) followed by a 35/70% Percoll gradient to isolate the lymphocyte-containing 
fraction.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Tissue-restricted self antigen-specific CD4+ T cells are not deleted
(A) Quantitative RT-PCR data depicting Cre mRNA expression levels normalized to 
GAPDH in indicated tissues of indicated mice. Mean values ±SEM of samples taken from at 
least two independent experiments are shown. (B) Representative flow cytometry of CD4+ 
single positive thymocytes following Cre:I-Ab tetramer-based cell enrichment of thymi. (C) 
Representative flow cytometry of peripheral CD4+ T cells following Cre:I-Ab tetramer-
based cell enrichment of pooled spleen and lymph nodes. Plots represent Dump(B220, 
CD11b, CD11c, F4/80)−CD3+CD4+ events as described in Figure S1E. Numbers above 
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gates indicate total numbers of Cre:I-Ab-specific CD4+T cells calculated for the whole 
mouse. (D–E) Quantitative summaries of Cre:I-Ab-specific CD4+ (D) thymocyte or (E) 
peripheral T cell numbers per mouse. Each datapoint represents an individual mouse. Mean 
values ±SEM are shown. Dotted lines represent the limit of detection as defined by the mean 
frequency of CD8+tetramer+ events. ns not significant, *** p<0.001, **** p<0.0001 for 
unpaired t tests between WT and each Cre mouse. See also Figure S1.
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Figure 2. Lung and intestinal self antigen-specific CD4+ T cells exhibit impaired proliferative 
responses
Mice were immunized with Cre peptide + CFA and analyzed 7 days later. (A) 
Representative flow cytometry of CD4+ T cells following Cre:I-Ab tetramer-based cell 
enrichment of pooled spleen and lymph nodes. Plots represent Dump(B220, CD11b, CD11c, 
F4/80)−CD3+CD4+ events. Numbers inside gates indicate total numbers of Cre:I-Ab-specific 
CD4+ T cells calculated for the whole mouse. (B) Quantitative summary of total Cre:I-Ab-
specific T cell numbers per mouse with fold expansion values indicated. The dotted line 
represents the limit of detection. (C) Linear regression analysis of Cre:I-Ab-specific T cell 
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numbers before and after immunization for each mouse strain. SEM, r2, and p values are 
indicated. (D) Tetramer mean fluorescence intensity (MFI), expressed in arbitrary units, of 
Cre:I-Ab-specific T cells from individual WT and Cre mice. Lines connect mice analyzed 
within the same experiment. (E) Quantitative summary of tetramer MFI from individual 
mice normalized to WT controls analyzed within the same experiment. (F) Linear regression 
analysis of Cre:I-Ab tetramer staining intensity and Cre:I-Ab-specific T cell expansion for 
each mouse strain. SEM, r2, and p values are indicated. (B,E) Mean values ±SEM are 
shown. ns not significant, * p<0.05, ** p<0.01, *** p<0.001 for unpaired t tests between 
WT and each Cre mouse. See also Figure S2.
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Figure 3. Lung and intestinal self antigen-specific CD4+ T cells exhibit impaired effector 
functions
Mice were immunized with Cre peptide + CFA and analyzed 7 days later. (A) 
Representative intracellular flow cytometry of IL-17 and IFNγ cytokine expression by Cre:I-
Ab-specific CD4+ T cells from pooled spleen and lymph nodes following in vitro 
restimulation with PMA + ionomycin. Numbers indicate proportions of cells in each 
quadrant. (B) Quantitative summary of the proportion of Cre:I-Ab-specific T cells 
expressing IL-17 in each mouse. (C) Representative flow cytometry of IL-17 and CXCR5 
expression by Cre:I-Ab-specific CD4+ T cells from a WT mouse. (D) Representative flow 
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cytometry of PD-1 and CXCR5 expression by Cre:I-Ab-specific CD4+ T cells. Numbers 
indicate proportions of cells in each gate. (E–F) Quantitative summaries of proportions of 
Cre:I-Ab-specific T cells exhibiting (E) CXCR5+ or (F) PD-1hiCXCR5hi GC-Tfh cell 
phenotypes. (B,E–F) Mean values ±SEM are shown. ns not significant, ** p<0.01, *** 
p<0.001, **** p<0.0001 for unpaired t tests between WT and each Cre mouse. See also 
Figure S3.
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Figure 4. Tolerance to lung and intestinal self antigen requires antigen-specific Tregs
(A) Representative flow cytometry depicting Foxp3EGFP reporter expression in CD4+ T 
cells following Cre:I-Ab tetramer-based cell enrichment of pooled spleen and lymph nodes 
from indicated naïve mice. Numbers indicate proportions of tetramer+ cells expressing 
Foxp3. (B) Quantitative summary of the proportion of Cre:I-Ab-specific CD4+ T cells 
expressing Foxp3 in each indicated mouse strain. (C) Quantitative summary of the total 
numbers of Foxp3+ and Foxp3− Cre:I-Ab-specific T cells in each indicated mouse strain. (D) 
Total Cre:I-Ab-specific T cell numbers and (E) proportions of IL-17+ Cre:I-Ab-specific T 
cells in indicated Foxp3-DEREG mice 7 days following peptide + CFA immunization with 
(closed symbols) or without (open symbols) concurrent Treg ablation by DT treatment. (F) 
WT host Cre:I-Ab-specific T cell numbers 7 days after adoptive transfer of ~4 × 106 
CD4+CD25+ Tregs from indicated donor mice followed by immunization with Cre peptide + 
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CFA. (B–F) Mean values ±SEM are shown. ns not significant, * p<0.05, ** p<0.01, **** 
p<0.0001 for unpaired t tests between WT and each Cre mouse. See also Figure S4.
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Figure 5. Tissue-restricted self antigen-specific Tregs are thymically derived and peripherally 
expanded
(A) Quantitative summary of the proportion of Cre:I-Ab-specific CD4+ SP thymocytes 
expressing Foxp3 in each indicated mouse strain. (B) Proportions of Cre:I-Ab-specific CD4+ 
T cells expressing Foxp3 in pooled spleen and lymph nodes from lethally irradiated WT or 
Foxp3ΔCNS1 mice reconstituted with WT or Foxp3ΔCNS1 bone marrow. (C) Proportions of 
Cre:I-Ab-specific T cells expressing Foxp3 in pooled spleen and lymph nodes from Aire−/− 
mice. (D) Proportions of Cre:I-Ab-specific T cells expressing Foxp3 in pooled spleen and 
lymph nodes from Batf3−/− mice. (E) Quantitative RT-PCR analysis of Insulin and Cre 
mRNA expression relative to β2M in flow sorted thymic epithelial cells (TECs). Mean 
values ±SEM of samples taken from at least two independent experiments are shown. (F) 
Proportions of Foxp3− (open symbols) or Foxp3+ (filled symbols) Cre:I-Ab-specific T cells 
expressing Ki67 in indicated mice. (A–D, F) Mean values ±SEM are shown. ns not 
significant, * p<0.05, ** p<0.01, *** p<0.001 for unpaired t tests between WT and each Cre 
mouse. See also Figure S5.
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Figure 6. Treg mediated tolerance to tissue-restricted self antigens is lost upon secondary 
immune challenge
(A) Mice were infected with Lm-Cre, and 4 weeks later rechallenged with Cre peptide + 
CFA. (B) Quantitative summary of total Cre:I-Ab-specific T cell numbers in pooled spleen 
and lymph nodes before and after secondary challenge with fold expansion values indicated. 
The dotted line represents the limit of detection. (C) Linear regression analysis of Cre:I-Ab-
specific T cell numbers before and after secondary immune challenge. SEM, r2, and p values 
are indicated. (D–E) Proportions of Cre:I-Ab-specific T cells (D) expressing IL-17 or IFNγ 
cytokines, or (E) exhibiting a GC-Tfh phenotype 7 days after secondary immune challenge. 
Legoux et al. Page 25
Immunity. Author manuscript; available in PMC 2016 November 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
(F) Cre:I-Ab-specific T cell numbers in the pancreas, lungs, and intestines of indicated mice 
7–9 days after primary or secondary immunization. Dotted lines represent the limit of 
detection. (G) Cre:I-Ab-specific T cell numbers in indicated tissues after secondary 
immunization, expressed as a percentage of total Cre:I-Ab-specific T cells from the whole 
mouse. (H) Blood glucose levels in naive WT or RIP-Cre mice 7–10 days after primary or 
secondary immunization. (B, D–H) Mean values ±SEM are shown. ns not significant, * 
p<0.05, ** p<0.01, *** p<0.001 for unpaired t tests between WT and each Cre mouse or 
between indicated conditions. See also Figure S6.
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Figure 7. The balance between Treg and Tconv is altered after immune challenge
Mice were infected with Lm-Cre and Cre:I-Ab-specific Tregs from the pooled spleen and 
lymph nodes were analyzed 4 weeks later. (A) Proportions of Cre:I-Ab-specific T cells 
expressing Foxp3. (B) Cre:I-Ab-specific T cell numbers in indicated mice. (C) WT host 
Cre:I-Ab-specific T cell numbers 7 days after adoptive transfer of ~4 × 106 CD4+CD25+ 
Tregs from indicated donor mice followed by immunization with Cre peptide + CFA. (A–C) 
Mean values ±SEM are shown. ns not significant, * p<0.05, ** p<0.01 for unpaired t tests 
between WT and each Cre mouse.
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